Skip to main content
. 2016 Dec 27;8(5):8484–8498. doi: 10.18632/oncotarget.14298

Figure 3. Dot-plots of miR -342-3p and let-7e expressions according to E-cadherin expression status.

Figure 3

miR-342-3p A. and let-7e B. exhibited lower expressions in patients with loss of E-cadherin in the ALK-rearranged, EGFR-mutated, and KRAS-mutated cancers (n = 52).